Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results
Authors
Keywords
Antigens, Drug therapy, Multiple sclerosis, Denmark, Drug screening, Europe, Sweden, Austria
Journal
PLoS One
Volume 12, Issue 2, Pages e0170395
Publisher
Public Library of Science (PLoS)
Online
2017-02-08
DOI
10.1371/journal.pone.0170395
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The clinical relevance of early anti-adalimumab antibodies detection in rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: A prospective multicentre study
- (2016) Ariela Hoxha et al. JOINT BONE SPINE
- Development and validation of cell-based luciferase reporter gene assays for measuring neutralizing anti-drug antibodies against interferon beta
- (2016) Christina Hermanrud et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Anti-Interferon Beta Antibody Titers Strongly Correlate Between Two Bioassays and In Vivo Biomarker Expression, and Indicates That a Titer of 150 TRU/mL Is a Biologically Functional Cut-Point
- (2014) Christina Hermanrud et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Human Leukocyte Antigen Genes and Interferon Beta Preparations Influence Risk of Developing Neutralizing Anti-Drug Antibodies in Multiple Sclerosis
- (2014) Jenny Link et al. PLoS One
- Socio-economic aspects of the testing for antibodies in MS-patients under interferon therapy in Austria: A cost of illness study
- (2014) Evelyn Walter et al. Multiple Sclerosis and Related Disorders
- Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development
- (2013) H Hegen et al. Multiple Sclerosis Journal
- Review of the pharmacoeconomics of early treatment of multiple sclerosis using interferon beta
- (2013) Florian Castrop et al. Neuropsychiatric Disease and Treatment
- Prediction of antibody persistency from antibody titres to natalizumab
- (2012) Poul Erik H Jensen et al. Multiple Sclerosis Journal
- Prevalence of anti-drug antibodies against interferon beta has decreased since routine analysis of neutralizing antibodies became clinical practice
- (2012) Roger Jungedal et al. Multiple Sclerosis Journal
- Characterization of anti-natalizumab antibodies in multiple sclerosis patients
- (2012) M Lundkvist et al. Multiple Sclerosis Journal
- Development of Antidrug Antibodies Against Adalimumab and Association With Disease Activity and Treatment Failure During Long-term Follow-up
- (2011) Geertje M. Bartelds JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Occurrence of antibodies against natalizumab in relapsing multiple sclerosis patients treated with natalizumab
- (2011) Per Soelberg Sørensen et al. Multiple Sclerosis Journal
- Neutralizing antibodies against interferon- do not predispose antibodies against natalizumab
- (2011) P. S. Sorensen et al. NEUROLOGY
- Effective knowledge management in translational medicine
- (2010) Sándor Szalma et al. Journal of Translational Medicine
- Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis
- (2010) Chris H Polman et al. LANCET NEUROLOGY
- Neutralizing Antibodies to Interferon-β and other Immunological Treatments for Multiple Sclerosis
- (2009) Florian Deisenhammer CNS DRUGS
- Absence of MxA induction by interferon in patients with MS reflects complete loss of bioactivity
- (2009) D. Hesse et al. NEUROLOGY
- HLA-DRB1∗0401 and HLA-DRB1∗0408 Are Strongly Associated with the Development of Antibodies against Interferon-β Therapy in Multiple Sclerosis
- (2008) Steve Hoffmann et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Validating parameters of a luciferase reporter gene assay to measure neutralizing antibodies to IFNβ in multiple sclerosis patients
- (2008) Regina Lam et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Quantification of Neutralizing Antibodies to Human Type I Interferons Using Division-Arrested Frozen Cells Carrying an Interferon-Regulated Reporter-Gene
- (2008) C. Lallemand et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More